Direct-to-Patient (Therapy)

The ability to expedite enrollment and retain patients throughout your clinical trial is key to the efficient commercialization and clinical development of your therapy. Ultimately, compressing a therapy's time in development can allow sponsor companies to better allocate resources and ensure patient populations throughout the world receive the treatment they need. That’s why pharmaceutical companies continue to look for more patient-centric solutions to attract and retain participants. A direct-to/from-patient (DTP/DFP) model is one such solution, adding convenience for patients who are unable or unwilling to travel to testing sites as well as extending your reach to include patients in remote areas who might not otherwise have been able to participate in your trial. As an expert in clinical trial logistics, QuickSTAT understands each DTP shipment requires its own unique supply chain, which we will help you design.